Hong Kong stocks fluctuate | Cornerstone Pharmaceuticals-B (02616.HK) rises by more than 5%, recently reached an exclusive commercial cooperation with Arrotex on the commercialization of SUGERI monoclonal antibodies in Australia and New Zealand.
According to the Wisdom Financial APP, Hengrui Pharmaceutical-B (02616.HK) has risen by over 5%, as of the time of reporting, it has risen by 3.85%, closing at 4.58 Hong Kong dollars, with a turnover of 1.6543 million Hong Kong dollars.
Latest
